Next Article in Journal
Prevalence of Multiple Antibiotics Resistant (MAR) Pseudomonas Species in the Final Effluents of Three Municipal Wastewater Treatment Facilities in South Africa
Next Article in Special Issue
Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
Previous Article in Journal
Scenario Simulation-Based Assessment of Trip Difficulty for Urban Residents under Rainstorm Waterlogging
Previous Article in Special Issue
The Aryl Hydrocarbon Receptor Pathway: A Key Component of the microRNA-Mediated AML Signalisome
Open AccessReview

Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents

Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, Tyne and Wear NE2 4HH, UK
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2012, 9(6), 2075-2091; https://doi.org/10.3390/ijerph9062075
Received: 2 May 2012 / Revised: 23 May 2012 / Accepted: 29 May 2012 / Published: 31 May 2012
(This article belongs to the Special Issue Leukemia Arising from Chemical Exposures and Chemotherapeutic Drugs)
Type II DNA topoisomerases have the ability to generate a transient DNA double-strand break through which a second duplex can be passed; an activity essential for DNA decatenation and unknotting. Topoisomerase poisons stabilize the normally transient topoisomerase-induced DSBs and are potent and widely used anticancer drugs. However, their use is associated with therapy-related secondary leukemia, often bearing 11q23 translocations involving the MLL gene. We will explain recent discoveries in the fields of topoisomerase biology and transcription that have consequences for our understanding of the etiology of leukemia, especially therapy-related secondary leukemia and describe how these findings may help minimize the occurrence of these neoplasias. View Full-Text
Keywords: topoisomerase II; TOP2; translocation; leukemia; AML; etoposide; mitoxantrone; epirubicin; transcription; carcinogen topoisomerase II; TOP2; translocation; leukemia; AML; etoposide; mitoxantrone; epirubicin; transcription; carcinogen
Show Figures

Graphical abstract

MDPI and ACS Style

Cowell, I.G.; Austin, C.A. Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents. Int. J. Environ. Res. Public Health 2012, 9, 2075-2091.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop